Health-related quality of life in young survivors of childhood cancer

L Wengenroth, M E Gianinazzi, C S Rueegg, S Lüer, E Bergstraesser, C E Kuehni, G Michel, L Wengenroth, M E Gianinazzi, C S Rueegg, S Lüer, E Bergstraesser, C E Kuehni, G Michel

Abstract

Purpose: Childhood cancer and its treatment may affect health-related quality of life (HRQoL) in childhood cancer survivors, but population-based studies in young survivors are scarce. We aimed to: (1) compare HRQoL between young survivors and population norms and (2) find factors that influence parent-reported HRQoL in survivors.

Methods: As part of the Swiss Childhood Cancer Survivor Study, a questionnaire was mailed to parents of survivors aged 8-16 years, registered in the Swiss Childhood Cancer Registry, ≥5 years after diagnosis. We used the KIDSCREEN-27 instrument to compare self- and parent-reported HRQoL between survivors (N = 425) and standardized norms in the five dimensions of physical well-being, psychological well-being, autonomy, peers and school environment (mean = 50, SD = 10). We then used multivariable linear regressions to test the influence of socio-demographic and cancer-related factors on HRQoL.

Results: Self-reported physical well-being was comparable to norms. Other HRQoL dimensions were higher than norms, with the highest mean = 52.2 (p < 0.001) for school environment. Parent-reported HRQoL in survivors was comparable to population norms; only physical well-being was lower (mean = 47.1, p < 0.001), and school environment was higher (mean = 51.1, p = 0.035). Parent-reported HRQoL was lower for survivors of CNS tumors (physical well-being: β = -5.27, p = 0.007; psychological well-being: β = -4.39, p = 0.044; peers β = -5.17, p = 0.028), survivors of neuroblastoma (psychological well-being β = -5.20, p = 0.047), and survivors who had had a relapse (physical well-being β = -5.41, p = 0.005).

Conclusions: Assessing HRQoL during follow-up care, with a focus on physical well-being, specific diagnoses (e.g., CNS tumor) and late complications (e.g., relapse) might help to early identify problems and offer support to survivors with reduced HRQoL.

References

    1. Pediatr Blood Cancer. 2011 Apr;56(4):646-53
    1. J Cancer Surviv. 2013 Dec;7(4):511-22
    1. JAMA. 2003 Sep 24;290(12):1583-92
    1. Pediatr Blood Cancer. 2008 May;50(5):1018-25
    1. Child Neuropsychol. 2008 Jul;14 (4):323-38
    1. Eur J Cancer. 2009 Apr;45(6):992-1005
    1. Health Qual Life Outcomes. 2007 Dec 03;5:65
    1. Child Care Health Dev. 2003 Mar;29(2):95-102
    1. Qual Life Res. 2014 Nov;23(9):2603-12
    1. Cancer. 2005 Oct 15;104(8):1751-60
    1. Lancet. 2007 Jun 30;369(9580):2171-2178
    1. Int J Epidemiol. 2012 Dec;41(6):1553-64
    1. PLoS One. 2012;7(5):e38015
    1. Psychooncology. 2014 Mar;23(3):266-75
    1. Pediatr Blood Cancer. 2006 Sep;47(3):312-9
    1. Pediatrics. 2007 Nov;120(5):e1229-36
    1. Acta Oncol. 2014 Apr;53(4):486-92
    1. N Engl J Med. 2006 Oct 12;355(15):1572-82
    1. Swiss Med Wkly. 2007 Sep 8;137(35-36):502-9
    1. Qual Life Res. 2007 Oct;16(8):1347-56
    1. CA Cancer J Clin. 2013 Jan;63(1):11-30
    1. Qual Life Res. 2012 Nov;21(9):1577-86
    1. Int J Cancer. 2007 Aug 1;121(3):633-40
    1. Pediatr Blood Cancer. 2007 Oct 15;49(5):704-15
    1. Support Care Cancer. 2005 Jan;13(1):49-56
    1. Cancer. 2002 Apr 1;94(7):2090-106
    1. Qual Life Res. 2007 Oct;16(8):1335-45
    1. J Clin Oncol. 2015 Feb 10;33(5):479-91
    1. Pediatr Blood Cancer. 2014 Oct;61(10):1891-4
    1. J Clin Oncol. 2005 Aug 20;23(24):5493-500
    1. Brain Inj. 2012;26(3):270-81
    1. Soc Psychiatry Psychiatr Epidemiol. 2013 Mar;48(3):503-11
    1. Health Qual Life Outcomes. 2013 Jun 13;11:96
    1. Eur J Oncol Nurs. 2008 Jul;12(3):209-16
    1. Qual Life Res. 2009 Nov;18(9):1147-57
    1. BMC Public Health. 2014 Aug 03;14:790
    1. Cancer. 2005 Apr 1;103(7):1457-67
    1. J Clin Oncol. 2009 May 10;27(14):2308-18
    1. Pediatr Transplant. 2010 Mar;14(2):216-23
    1. Qual Life Res. 2007 Jun;16(5):863-71
    1. Br J Cancer. 2009 Jan 13;100(1):82-8
    1. J Rehabil Med. 2011 Jun;43(7):584-9
    1. PLoS One. 2012;7(10):e47944
    1. Eur J Cancer. 2007 Nov;43(17):2545-52

Source: PubMed

3
S'abonner